The New Concepts Symposium is sponsored by independent biopharmaceutical company Specialised Therapeutics Australia, in a key demonstration of its commitment to cancer research and the development of new therapeutics that may change lives.
Pictured: Dr Geddes receiving her Best of New Concepts Award from Professor Tim Price, Chair AGITG and Nikoletta Mcleod, Specialised Therapeutics Australia
The New Concepts Symposium is designed as a novel way to reach out to a wider spectrum of the AGITG. The Symposium provides an opportunity for delegates to present embryonic new concepts for feedback and discussion with the audience as well as comments from international guests in terms of perspective, international interest and relevance.
In 2017, the Symposium featured four excellent presentations of embryonic research concepts. This year the Award was presented to Dr Katherine Geddes for her research project titled: The prevalence and significance of sarcopaenia in patients with operable adenocarcinoma of the stomach or gastro‐oesophageal junction undergoing treatment with curative intent and the impact of altered body composition on chemotherapy delivery.
“I am very humbled to receive the Best of New Concepts award for 2017, especially considering that the research projects presented this year were so highly commended,” said Dr Katherine Geddes. “Receiving this award from the AGITG is enormously encouraging for young female investigators and I am excited that this project, with the support received from the AGITG, might one day become a reality.”
Specialised Therapeutics Australia Chief Executive Officer Mr Carlo Montagner said he looked forward to seeing the concept evolve.
“Supporting this kind of research provides another opportunity for us to contribute to the ‘big picture’ of improving patient outcomes in the long term,” he said. “Our mission is not only to provide specialist medicines. We are committed to collaborating and contributing where appropriate, in order to make a difference.”
The AGITG thanks Specialised Therapeutics Australia for their continued support of the Best of New Concepts Symposium.